Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Nephrology, Dialysis and Transplantation

• Publication date

  2009-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/ndt/gfn746PMID 19155534
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of the combination of N-acetylcysteine and desferrioxamine in the prevention and treatment of gentamicin-induced acute renal failure in male Wistar rats.

  2009cited by this paper
• BMP-7 protects mesangial cells from injury by polymeric IgA.

  2008cited by this paper
• Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.

  2008cited by this paper
• Peroxisome proliferator activated receptor gamma agonists suppress TNFalpha-induced ICAM-1 expression by endothelial cells in a manner potentially dependent on inhibition of reactive oxygen species.

  2008cited by this paper
• Synthesis of TNF-alpha by mesangial cells cultured with polymeric anionic IgA--role of MAPK and NF-kappaB.

  2008cited by this paper
• Activation of podocytes by mesangial-derived TNF-alpha: glomerulo-podocytic communication in IgA nephropathy.

  2008cited by this paper
• Reduction of proteinuria by rosiglitazone in non‐diabetic renal disease

  2007cited by this paper
• Glycosylation Profile of Differently Charged IgA1 and Their Binding Characteristics to Cultured Mesangial Cells in IgA Nephropathy

  2007cited by this paper
• Rosiglitazone decreases albuminuria in type 2 diabetic patients.

  2007cited by this paper
• Immunopathogenesis of IgAN

  2007cited by this paper
• Synthesis of TNF-α by mesangial cells cultured with polymeric anionic IgA—role of MAPK and NF-κB

  2007cited by this paper
• Quantitative appraisal of treatment options for IgA nephropathy.

  2007cited by this paper
• Rosiglitazone Increases PPARγ in Renal Tubular Epithelial Cells and Protects against Damage by Hydrogen Peroxide

  2007cited by this paper
• Activation of tubular epithelial cells in diabetic nephropathy and the role of the peroxisome proliferator-activated receptor-gamma agonist.

  2006cited by this paper
• The PPARγ agonist pioglitazone modifies the vascular sodium-angiotensin II relationship in insulin-resistant rats

  2006cited by this paper
• Telmisartan downregulates angiotensin II type 1 receptor through activation of peroxisome proliferator-activated receptor gamma.

  2006cited by this paper
• Neuronal Angiotensin II Type 1 Receptor Upregulation in Heart Failure: Activation of Activator Protein 1 and Jun N-Terminal Kinase

  2006cited by this paper
• The PPARgamma agonist pioglitazone modifies the vascular sodium-angiotensin II relationship in insulin-resistant rats.

  2006cited by this paper
• The IgA nephropathy treatment dilemma.

  2006cited by this paper
• Protection of the kidney by thiazolidinediones: an assessment from bench to bedside.

  2006cited by this paper
• PPARgamma agonists exert antifibrotic effects in renal tubular cells exposed to high glucose.

  2005cited by this paper
• Pioglitazone attenuates TGF‐β1‐induction of fibronectin synthesis and its splicing variant in human mesangial cells via activation of peroxisome proliferator‐activated receptor (PPAR)γ

  2005cited by this paper
• Activation of tubular epithelial cells by mesangial-derived TNF-alpha: glomerulotubular communication in IgA nephropathy.

  2005cited by this paper
• Anti‐inflammatory Effect of PPARγ in Cultured Human Mesangial Cells

  2004cited by this paper
• Expression of peroxisome proliferator-activated receptor isoform proteins in the rat kidney.

  2004cited by this paper
• Pioglitazone increases renal tubular cell albumin uptake but limits proinflammatory and fibrotic responses.

  2004cited by this paper
• Anti-inflammatory effect of PPARgamma in cultured human mesangial cells.

  2004cited by this paper
• Troglitazone Inhibits Isolated Cell Proliferation, and Induces Apoptosis in Isolated Rat Mesangial Cells

  2003cited by this paper
• Angiotensin Type 2 Receptor (AT2R): A Challenging Twin

  2003cited by this paper
• Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the renin-angiotensin system.

  2003influential reference
• IgA nephropathy.

  2002cited by this paper
• Transcription factor NF-kappa B is necessary for up-regulation of type 1 angiotensin II receptor mRNA in rat cardiac fibroblasts treated with tumor necrosis factor-alpha or interleukin-1 beta.

  2002cited by this paper
• Transcription Factor NF-κB Is Necessary for Up-regulation of Type 1 Angiotensin II Receptor mRNA in Rat Cardiac Fibroblasts Treated with Tumor Necrosis Factor-α or Interleukin-1β*

  2002cited by this paper
• Troglitazone suppresses the secretion of type I collagen by mesangial cells in vitro.

  2002cited by this paper
• Activation of tubular epithelial cells in diabetic nephropathy.

  2002cited by this paper
• Transcriptional Suppression of Type 1 Angiotensin II Receptor Gene Expression by Peroxisome Proliferator-Activated Receptor-γ in Vascular Smooth Muscle Cells.

  2001cited by this paper
• Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells.

  2001cited by this paper
• Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats.

  2001cited by this paper
• PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

  2001cited by this paper
• Peroxisome proliferator-activated receptor gamma activators downregulate angiotensin II type 1 receptor in vascular smooth muscle cells.

  2000cited by this paper
• Peroxisome Proliferator-Activated Receptor γ Activators Downregulate Angiotensin II Type 1 Receptor in Vascular Smooth Muscle Cells

  2000cited by this paper
• Tubular lesions determine prognosis of IgA nephropathy.

  2000cited by this paper
• Peroxisome proliferator-activated receptors: nuclear control of metabolism.

  1999cited by this paper
• The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation

  1998cited by this paper
• The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation.

  1998cited by this paper
• Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans.

  1997cited by this paper
• Molecular Cloning, Expression and Characterization of Human Peroxisome Proliferator Activated Receptors γ1 and γ2

  1996cited by this paper
• Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2.

  1996influential reference

• Metabolic Checkpoints in IgA Nephropathy: From Pathogenesis to Precision Medicine.

  2026cites this paper
• Integrative bioinformatics analysis unveils hub transcription factors and their interacting drugs in immunoglobulin A nephropathy: Implications for pathogenesis and treatments

  2025cites this paper
• GPX4 expression changes in proximal tubule cells highlight the role of ferroptosis in IgAN

  2025cites this paper
• Peroxisome proliferator-activated receptor gamma and its natural agonists in the treatment of kidney diseases

  2022cites this paper
• Role of Human Mesangial-Tubular Crosstalk in Secretory IgA-Induced IgA Nephropathy

  2021cites this paper
• PPARγ and Its Agonists in Chronic Kidney Disease

  2020cites this paper
• Zhen-wu-tang protects against podocyte injury in rats with IgA nephropathy via PPARγ/NF-κB pathway.

  2018cites this paper
• Progress in the Mechanism of IgA Nephropathy Renal Injury

  2018cites this paper
• Toll-like Receptor 4 Signaling Pathway in the Protective Effect of Pioglitazone on Experimental Immunoglobulin A Nephropathy

  2017cites this paper
• Clinical and pathological analysis of IgA nephropathy with chronic renal failure

  2016cites this paper
• Soluble monosodium urate, but not its crystal, induces toll like receptor 4-dependent immune activation in renal mesangial cells.

  2015cites this paper
• Crosstalk between peroxisome proliferator-activated receptor-γ and mineralcorticoid receptor in TNF-α activated renal tubular cell

  2015cites this paper
• Update on immunoglobulin A nephropathy, Part I: Pathophysiology.

  2015cites this paper
• Association of peroxisome proliferator-activated receptors/retinoic acid receptors with renal diseases

  2013cites this paper
• L-165,041, troglitazone and their combination treatment to attenuate high glucose-induced receptor for advanced glycation end products (RAGE) expression.

  2013cites this paper
• PPAR&ggr; as a therapeutic target in diabetic nephropathy and other renal diseases

  2012cites this paper
• A DISSERTATION ON HISTOPATHOLOGICAL ASSESSMENT OF PROGNOSIS OF IGA NEPHROPATHY

  2012cites this paper
• PPAR-γ agonists in polycystic kidney disease with frequent development of cardiovascular disorders.

  2012cites this paper
• Serum IL-18 Is Closely Associated with Renal Tubulointerstitial Injury and Predicts Renal Prognosis in IgA Nephropathy

  2012cites this paper
• Urinary interleukin-6 (IL-6) and transforming growth factor (TGF-β) levels in corticosteroidtreated patients with IgA nephropathy.

  2011cites this paper
• Primary IgA nephropathy: new insights into pathogenesis.

  2011cites this paper
• Additive effect of PPAR-γ agonist and ARB in treatment of experimental IgA nephropathy

  2011influential citation
• Crosstalk between peroxisome proliferator-activated receptor-gamma and angiotensin II in renal tubular epithelial cells in IgA nephropathy.

  2009cites this paper
• Beneficial effect of pioglitazone in proteinuric IgA nephropathy with concomitant ACEI/ARB treatment.

  2009cites this paper
• Regulation of amino acid transporters in the rat remnant kidney.

  2009cites this paper